Eisai: Angle updates on AstraZeneca development work and Eisai's phase 2 pilot study
Angle Inc, a world─leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample, has
Read full article »
Eisai is a Japan-based pharmaceutical company that develops and commercializes prescription medicines and OTC drugs for the healthcare sector.
Read more